메뉴 건너뛰기




Volumn 5, Issue 9, 2007, Pages 1835-1838

Platelet function, antiplatelet therapy and clinical outcomes: To test or not to test?

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CYCLOOXYGENASE 1; IBUPROFEN; INDOMETACIN;

EID: 34548077770     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02655.x     Document Type: Note
Times cited : (11)

References (43)
  • 1
    • 0028120906 scopus 로고
    • Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
    • Antiplatelet Trialists' Collaboration
    • Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106.
    • (1994) BMJ , vol.308 , pp. 81-106
  • 2
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
    • Antithrombotic Trialists' Collaboration
    • Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86.
    • (2002) BMJ , vol.324 , pp. 71-86
  • 3
    • 0024746737 scopus 로고
    • Predictive value of factors of the hemostatic system in screening procedures for coronary artery disease
    • van de Loo JC. Predictive value of factors of the hemostatic system in screening procedures for coronary artery disease. Ric Clin Lab 1989; 19: 333-8.
    • (1989) Ric Clin Lab , vol.19 , pp. 333-338
    • van de Loo, J.C.1
  • 4
    • 0026783457 scopus 로고
    • The PLAT Study: Hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group
    • Cortellaro M, Boschetti C, Cofrancesco E, Zanussi C, Catalano M, de Gaetano G, Gabrielli L, Lombardi B, Specchia G, Tavazzi L. The PLAT Study: Hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group. Arterioscler Thromb. 1992; 12: 1063-70.
    • (1992) Arterioscler Thromb , vol.12 , pp. 1063-1070
    • Cortellaro, M.1    Boschetti, C.2    Cofrancesco, E.3    Zanussi, C.4    Catalano, M.5    de Gaetano, G.6    Gabrielli, L.7    Lombardi, B.8    Specchia, G.9    Tavazzi, L.10
  • 5
    • 0020326485 scopus 로고
    • Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: A difficult link
    • de Gaetano G, Cerletti C, Bertele V. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: A difficult link. Lancet 1982; 2: 974-7.
    • (1982) Lancet , vol.2 , pp. 974-977
    • de Gaetano, G.1    Cerletti, C.2    Bertele, V.3
  • 6
    • 24944474901 scopus 로고    scopus 로고
    • Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis; Working Group on Aspirin Resistance. Aspirin resistance: Position paper of the Working Group on Aspirin Resistance
    • Michelson AD, Cattaneo M, Eikelboom JW, Gurbel P, Kottke-Marchant K, Kunicki TJ, Pulcinelli FM, Cerletti C, Rao AK. Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis; Working Group on Aspirin Resistance. Aspirin resistance: Position paper of the Working Group on Aspirin Resistance. J Thromb Haemost 2005; 3: 1309-11.
    • (2005) J Thromb Haemost , vol.3 , pp. 1309-1311
    • Michelson, A.D.1    Cattaneo, M.2    Eikelboom, J.W.3    Gurbel, P.4    Kottke-Marchant, K.5    Kunicki, T.J.6    Pulcinelli, F.M.7    Cerletti, C.8    Rao, A.K.9
  • 7
    • 8344231455 scopus 로고    scopus 로고
    • Aspirin and clopidogrel: Efficacy, safety, and the issue of drug resistance
    • Cattaneo M. Aspirin and clopidogrel: Efficacy, safety, and the issue of drug resistance. Arterioscler Thromb Vasc Biol 2004; 24: 1980-7.
    • (2004) Arterioscler Thromb Vasc Biol , vol.24 , pp. 1980-1987
    • Cattaneo, M.1
  • 9
    • 34247521816 scopus 로고    scopus 로고
    • Variable platelet response to aspirin and clopidogrel in atherothrombotic disease
    • Maree AO, Fitzgerald DJ. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. Circulation 2007; 115: 2196-207.
    • (2007) Circulation , vol.115 , pp. 2196-2207
    • Maree, A.O.1    Fitzgerald, D.J.2
  • 12
    • 34548062503 scopus 로고    scopus 로고
    • Response variability to aspirin as assessed by a platelet function analyzing device in 5,700 subjects: A systematic review of 40 studies
    • Crescente M, Di Castelnuovo A, Iacoviello L, Vermylen J, Cerletti C, de Gaetano G. Response variability to aspirin as assessed by a platelet function analyzing device in 5,700 subjects: A systematic review of 40 studies. J Thromb Haemost 2007; 5 (Suppl. 1): P-S-309.
    • (2007) J Thromb Haemost , vol.5 , Issue.SUPPL. 1
    • Crescente, M.1    Di Castelnuovo, A.2    Iacoviello, L.3    Vermylen, J.4    Cerletti, C.5    de Gaetano, G.6
  • 13
    • 0016390072 scopus 로고
    • Indomethacin and platelet aggregation in chronic glomerulonephritis: Existence of non-responders
    • de Gaetano G, Vermylen J, Donati MB, Dotremont G, Michielsen P. Indomethacin and platelet aggregation in chronic glomerulonephritis: existence of non-responders. Br Med J 1974; 2: 301-3.
    • (1974) Br Med J , vol.2 , pp. 301-303
    • de Gaetano, G.1    Vermylen, J.2    Donati, M.B.3    Dotremont, G.4    Michielsen, P.5
  • 14
    • 0019430713 scopus 로고
    • Inhibition of thromboxane synthetase does not necessarily prevent platelet aggregation
    • Bertelé V, Cerletti C, Schieppati A, Di Minno G, de Gaetano G. Inhibition of thromboxane synthetase does not necessarily prevent platelet aggregation. Lancet 1981; 1: 1057-8.
    • (1981) Lancet , vol.1 , pp. 1057-1058
    • Bertelé, V.1    Cerletti, C.2    Schieppati, A.3    Di Minno, G.4    de Gaetano, G.5
  • 15
    • 0020639135 scopus 로고
    • Human blood platelet behaviour after inhibition of thromboxane synthetase
    • Heptinstall S, Fox SC. Human blood platelet behaviour after inhibition of thromboxane synthetase. Br J Clin Pharmacol 1983; 15 (Suppl. 1): 31S-7S.
    • (1983) Br J Clin Pharmacol , vol.15 , Issue.SUPPL. 1
    • Heptinstall, S.1    Fox, S.C.2
  • 16
    • 0021252763 scopus 로고
    • Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: Modulatory role of cyclooxygenase products
    • Bertelé V, Falanga A, Tomasiak M, Chiabrando C, Cerletti C, de Gaetano G. Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: Modulatory role of cyclooxygenase products. Blood 1984; 63: 1460-6.
    • (1984) Blood , vol.63 , pp. 1460-1466
    • Bertelé, V.1    Falanga, A.2    Tomasiak, M.3    Chiabrando, C.4    Cerletti, C.5    de Gaetano, G.6
  • 17
    • 0023800094 scopus 로고
    • Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders
    • Gresele P, Blockmans D, Deckmyn H, Vermylen J. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders. J Pharmacol Exp Ther 1988; 246: 301-7.
    • (1988) J Pharmacol Exp Ther , vol.246 , pp. 301-307
    • Gresele, P.1    Blockmans, D.2    Deckmyn, H.3    Vermylen, J.4
  • 18
    • 0019466241 scopus 로고
    • Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition
    • Dejana E, Cerletti C, De Castellarnau C, Livio M, Galletti F, Latini R, de Gaetano G. Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition. J Clin Invest 1981; 68: 1108-12.
    • (1981) J Clin Invest , vol.68 , pp. 1108-1112
    • Dejana, E.1    Cerletti, C.2    De Castellarnau, C.3    Livio, M.4    Galletti, F.5    Latini, R.6    de Gaetano, G.7
  • 19
    • 0020049595 scopus 로고
    • Non-steroidal anti-inflammatory drugs react with two sites on platelet cyclo-oxygenase. Evidence from 'in vivo' drug interaction studies in rats
    • Cerletti C, Livio M, de Gaetano G. Non-steroidal anti-inflammatory drugs react with two sites on platelet cyclo-oxygenase. Evidence from 'in vivo' drug interaction studies in rats. Biochim Biophys Acta 1982; 714: 122-8.
    • (1982) Biochim Biophys Acta , vol.714 , pp. 122-128
    • Cerletti, C.1    Livio, M.2    de Gaetano, G.3
  • 20
    • 0021352475 scopus 로고
    • Structural requirements for preventing the aspirin- and the arachidonate-induced inactivation of platelet cyclo-oxygenase: Additional evidence for distinct enzymatic sites
    • Rotilio D, Joseph D, Hatmi M, Vargaftig BB. Structural requirements for preventing the aspirin- and the arachidonate-induced inactivation of platelet cyclo-oxygenase: Additional evidence for distinct enzymatic sites. Eur J Pharmacol 1984; 97: 197-208.
    • (1984) Eur J Pharmacol , vol.97 , pp. 197-208
    • Rotilio, D.1    Joseph, D.2    Hatmi, M.3    Vargaftig, B.B.4
  • 21
    • 0022371180 scopus 로고
    • Pharmacology of platelet inhibition in humans: Implications of the salicylate-aspirin interaction
    • de Gaetano G, Cerletti C, Dejana E, Latini R. Pharmacology of platelet inhibition in humans: Implications of the salicylate-aspirin interaction. Circulation 1985; 72: 1185-93.
    • (1985) Circulation , vol.72 , pp. 1185-1193
    • de Gaetano, G.1    Cerletti, C.2    Dejana, E.3    Latini, R.4
  • 22
    • 0020360347 scopus 로고
    • Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity
    • Livio M, Del Maschio A, Cerletti C, de Gaetano G. Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity. Prostaglandins 1982; 23: 787-96.
    • (1982) Prostaglandins , vol.23 , pp. 787-796
    • Livio, M.1    Del Maschio, A.2    Cerletti, C.3    de Gaetano, G.4
  • 23
    • 0020558909 scopus 로고
    • Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin
    • Rao GH, Johnson GG, Reddy KR, White JG. Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin. Arteriosclerosis 1983; 3: 383-8.
    • (1983) Arteriosclerosis , vol.3 , pp. 383-388
    • Rao, G.H.1    Johnson, G.G.2    Reddy, K.R.3    White, J.G.4
  • 24
    • 0029056992 scopus 로고
    • The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase
    • Loll PJ, Picot D, Garavito RM. The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nat Struct Biol 1995; 2: 637-43.
    • (1995) Nat Struct Biol , vol.2 , pp. 637-643
    • Loll, P.J.1    Picot, D.2    Garavito, R.M.3
  • 26
    • 0037442182 scopus 로고    scopus 로고
    • Effect of ibuprofen on cardioprotective effect of aspirin
    • MacDonald TM, Wei L. Effect of ibuprofen on cardioprotective effect of aspirin. Lancet 2003; 361: 573-4.
    • (2003) Lancet , vol.361 , pp. 573-574
    • MacDonald, T.M.1    Wei, L.2
  • 27
    • 0141851094 scopus 로고    scopus 로고
    • Aspirin resistance: Definition, mechanisms and clinical read-outs
    • Patrono C. Aspirin resistance: Definition, mechanisms and clinical read-outs. J Thromb Haemost 2003; 1: 1710-3.
    • (2003) J Thromb Haemost , vol.1 , pp. 1710-1713
    • Patrono, C.1
  • 28
    • 0141627621 scopus 로고    scopus 로고
    • Aspirin resistance: A revival of platelet aggregation tests?
    • de Gaetano G, Cerletti C. Aspirin resistance: A revival of platelet aggregation tests? J Thromb Haemost 2003; 1: 2048-50.
    • (2003) J Thromb Haemost , vol.1 , pp. 2048-2050
    • de Gaetano, G.1    Cerletti, C.2
  • 29
    • 17144396926 scopus 로고    scopus 로고
    • Platelet function testing in cardiovascular diseases
    • Michelson AD. Platelet function testing in cardiovascular diseases. Circulation 2004; 110: E489-93.
    • (2004) Circulation , vol.110
    • Michelson, A.D.1
  • 30
    • 0346367328 scopus 로고
    • Aggregation of blood platelets by adenosine diphosphate and its reversal
    • Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-9.
    • (1962) Nature , vol.194 , pp. 927-929
    • Born, G.V.R.1
  • 31
    • 0001332609 scopus 로고
    • Platelet aggregation. Part II: Some results of a new method
    • O'Brien JR. Platelet aggregation. Part II: Some results of a new method. J Clin Pathol 1962; 194: 452-5.
    • (1962) J Clin Pathol , vol.194 , pp. 452-455
    • O'Brien, J.R.1
  • 34
    • 15944383861 scopus 로고    scopus 로고
    • Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases
    • Aleil B, Ravanat C, Cazenave JP, Rochoux G, Heitz A, Gachet C. Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost 2005; 3: 85-92.
    • (2005) J Thromb Haemost , vol.3 , pp. 85-92
    • Aleil, B.1    Ravanat, C.2    Cazenave, J.P.3    Rochoux, G.4    Heitz, A.5    Gachet, C.6
  • 35
    • 33845366186 scopus 로고    scopus 로고
    • Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor
    • Pampuch A, Cerletti C, de Gaetano G. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor. Thromb Haemost 2006; 96: 767-73.
    • (2006) Thromb Haemost , vol.96 , pp. 767-773
    • Pampuch, A.1    Cerletti, C.2    de Gaetano, G.3
  • 37
    • 0038649988 scopus 로고    scopus 로고
    • Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity
    • Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003; 107: 2908-13.
    • (2003) Circulation , vol.107 , pp. 2908-2913
    • Gurbel, P.A.1    Bliden, K.P.2    Hiatt, B.L.3    O'Connor, C.M.4
  • 38
    • 9644281093 scopus 로고    scopus 로고
    • The difference between clopidogrel responsiveness and posttreatment platelet reactivity
    • Samara WM, Bliden KP, Tantry US, Gurbel PA. The difference between clopidogrel responsiveness and posttreatment platelet reactivity. Thromb Res 2005; 115: 89-94.
    • (2005) Thromb Res , vol.115 , pp. 89-94
    • Samara, W.M.1    Bliden, K.P.2    Tantry, U.S.3    Gurbel, P.A.4
  • 39
    • 1642289998 scopus 로고    scopus 로고
    • The epidemiological night where all patients are black: Will pharmacogenetics shed some light?
    • de Gaetano G, Cerletti C, Iacoviello L, Donati MB. The epidemiological night where all patients are black: Will pharmacogenetics shed some light? Thromb Res 2003; 112: 273-4.
    • (2003) Thromb Res , vol.112 , pp. 273-274
    • de Gaetano, G.1    Cerletti, C.2    Iacoviello, L.3    Donati, M.B.4
  • 41
    • 0037046196 scopus 로고    scopus 로고
    • Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
    • Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 2002; 105: 1650-5.
    • (2002) Circulation , vol.105 , pp. 1650-1655
    • Eikelboom, J.W.1    Hirsh, J.2    Weitz, J.I.3    Johnston, M.4    Yi, Q.5    Yusuf, S.6
  • 42
    • 0037454168 scopus 로고    scopus 로고
    • A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease
    • Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003; 41: 961-5.
    • (2003) J Am Coll Cardiol , vol.41 , pp. 961-965
    • Gum, P.A.1    Kottke-Marchant, K.2    Welsh, P.A.3    White, J.4    Topol, E.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.